About Stemcentrx
Stemcentrx provides pharmaceutical services.
Headquarters
Stemcentrx, South San Francisco
Founded
2008-01-01
Industry
Alternative Medicine, Biotechnology, Health Diagnostics, Pharmaceutical, Therapeutics
Last Funding Type
Series G
Valuation
26
Total Funding
$515.53 million dollars
IPO Status
Private
Financial
Funding Rounds
4
Number of Lead Investors
3
Total Funding Amount
$515.53 million dollars
Number of Investors
8
Stemcentrx vs. Other Decacorns
Company | Valuation | Total Funding | Funding Rounds |
---|---|---|---|
Stemcentrx | $26B | $515.53M | 4 |
Theranos | $11B | $1.37B | 10 |
Neuralink | $4B | $686.24M | 7 |
Oxford Nanopore Technologies | $4.5B | $1.56B | 20 |
Polygon | $4B | $4.23M | 2 |
Altos Labs | $3B | $3.00B | 1 |
MindMaze | $2B | $340.66M | 10 |
Viridos | $1B | $202.00M | 10 |
Insightec | $3B | $882.90M | 12 |
Editas Medicine | $0.6B | $931.60M | 7 |
Adimab | $1B | $45.48M | 8 |
Synthego | $1B | $459.69M | 9 |
Foundation Medicine | $0.5B | $96.50M | 4 |
GRAIL | $1.1B | $2.00B | 5 |
Freenome | $1B | $1.35B | 9 |
Kallyope | $1B | $487.20M | 6 |
23andMe | $3.5B | $1.12B | 14 |
Human Longevity | $50B | $369.80M | 5 |
Schroedinger | $0.8B | $577.22M | 10 |
ATAI Life Sciences | $2.3B | $522.10M | 11 |
SWORD Health | $2B | $453.47M | 11 |
Solugen | $4B | $855.77M | 10 |
SonderMind | $1B | $183.04M | 6 |
Livongo | $2.5B | $235.00M | 6 |
Cue Health | $2.3B | $899.60M | 11 |
Pivot Bio | $2B | $616.90M | 7 |
Everly Health | $10B | - | 1 |
GreenLight Biosciences | $1.2B | $449.50M | 10 |
Medable | $2B | $506.64M | 9 |
Athelas | $9B | $150.13M | 5 |
Ro | $33B | $1.03B | 8 |
Modern Health | $4B | $167.40M | 6 |
Benchling | $37B | $411.90M | 9 |
Flatiron Health | $21B | $324.95M | 4 |
Alto Pharmacy | $3B | $680.03M | 11 |
Twist Bioscience | $0.4B | $553.11M | 10 |
Ginger | $15B | $222.42M | 11 |
AbCellera Biologics | $5.3B | $886.98M | 11 |
Ganymed Pharmaceuticals | $1B | $212.70M | 5 |
Owkin | $3B | $304.10M | 8 |
Apeel Sciences | $2B | $719.06M | 12 |
Investment history
Round number | date | Post-round evaluation | investors |
---|---|---|---|
№1 | 09.09.2015 | $250.00 million dollars |
Fidelity |
№2 | 30.05.2014 | $200.00 million dollars | |
№3 | 01.07.2012 | $42.00 million dollars |
Founders Fund |
№4 | 16.03.2011 | $23.53 million dollars |
Artis Ventures (AV) |